Buprenorphine Extended-Release Injection and Xpovio (100 MG Once Weekly)
Determining the interaction of Buprenorphine Extended-Release Injection and Xpovio (100 MG Once Weekly) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: selinexor
Brand name: Xpovio
Synonyms: Xpovio
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine Extended-Release Injection-Xpovio (60 MG Once Weekly)
- Buprenorphine Extended-Release Injection-Xpovio (80 MG Once Weekly)
- Buprenorphine Extended-Release Injection-Xpovio (80 MG Twice Weekly)
- Buprenorphine Extended-Release Injection-Xryliderm
- Buprenorphine Extended-Release Injection-Xrylix
- Buprenorphine Extended-Release Injection-Xtampza ER
- Xpovio (100 MG Once Weekly)-Buprenorphine implant
- Xpovio (100 MG Once Weekly)-Buprenorphine Injection
- Xpovio (100 MG Once Weekly)-Buprenorphine injection - Buprenex
- Xpovio (100 MG Once Weekly)-Buprenorphine injection - Sublocade
- Xpovio (100 MG Once Weekly)-Buprenorphine Intradermal
- Xpovio (100 MG Once Weekly)-Buprenorphine oral/buccal